Inventor
PFAHL MAGNUS
US24 patents
⚠️ This page may combine multiple inventors who share the name “PFAHL MAGNUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JOLLA CANCER RES FOUND
5 patentsUS5552271ASep 3, 1996
RXR homodimer formation
JOLLA CANCER RES FOUND15 citations81
US5144007ASep 1, 1992
Thyroid hormone receptor
JOLLA CANCER RES FOUND11 citations74
US5824484AOct 20, 1998
RXR homodimer formation
JOLLA CANCER RES FOUND10 citations73
US5183736AFeb 2, 1993
Methods using estrogen receptor as a constitutive transcriptional activator and a repressor
JOLLA CANCER RES FOUND15 citations68
US6004748ADec 21, 1999
Method of inhibiting transcription utilizing nuclear receptors
JOLLA CANCER RES FOUND1 citations52
ORTHO MCNEIL PHARM INC
5 patentsUS6974826B2Dec 13, 2005
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
ORTHO MCNEIL PHARM INC5 citations73
US7196108B2Mar 27, 2007
Bicyclic heterocycles for the treatment of diabetes and other diseases
ORTHO MCNEIL PHARM INC7 citations71
US7102000B2Sep 5, 2006
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
ORTHO MCNEIL PHARM INC9 citations70
US7071218B2Jul 4, 2006
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
ORTHO MCNEIL PHARM INC10 citations70
US7226940B2Jun 5, 2007
Substituted heterocycles for the treatment of diabetes and other diseases
ORTHO MCNEIL PHARM INC3 citations62
BURNHAM INST
4 patentsUS6335159B1Jan 1, 2002
Retinoic acid receptor ε(rarε)
BURNHAM INST4 citations63
US5643720AJul 1, 1997
Method of inhibiting transcription utilizing nuclear receptors
BURNHAM INST4 citations63
US5712093AJan 27, 1998
RXR homodimer formation
BURNHAM INST3 citations62
US6683047B1Jan 27, 2004
Method of inhibiting transcription utilizing nuclear receptors
BURNHAM INST1 citations52
GALDERMA RES & DEV
3 patentsUS6462064B1Oct 8, 2002
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
GALDERMA RES & DEV25 citations90
US6127415AOct 3, 2000
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
GALDERMA RES & DEV41 citations90
US6825226B2Nov 30, 2004
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
GALDERMA RES & DEV2 citations60
STANFORD RES INST INT
2 patentsUS5466861ANov 14, 1995
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
STANFORD RES INST INT168 citations96
US5837725ANov 17, 1998
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
STANFORD RES INST INT8 citations73